Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?
- PMID: 22929559
- DOI: 10.1038/mi.2012.82
Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?
Abstract
While only partial immune reconstitution in gut-associated lymphoid tissue typically occurs following initiation of highly active antiretroviral therapy (HAART) in human immunodeficiency virus (HIV) infection, near-complete immune reconstitution has occasionally been described. This review highlights findings from studies examining the effects of HAART and the timing of its initiation on gastrointestinal (GI) CD4+ T-cell recovery. Its effects on specific CD4+ T-cell subtypes, CD8+ T cells, natural killer cells, and immunoglobulins are also described. Finally, the ability of HAART to restore the intestinal epithelial barrier and lymphatic tissue architecture and reduce microbial translocation is addressed. Determining whether HAART has the ability to prevent permanent GI immune damage when commenced in acute HIV infection has implications for the optimal timing of HAART initiation.
Similar articles
-
Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.J Virol. 2003 Nov;77(21):11708-17. doi: 10.1128/jvi.77.21.11708-11717.2003. J Virol. 2003. PMID: 14557656 Free PMC article.
-
Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?Curr Opin Infect Dis. 2014 Jun;27(3):275-81. doi: 10.1097/QCO.0000000000000059. Curr Opin Infect Dis. 2014. PMID: 24739345 Review.
-
Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.Front Immunol. 2021 May 31;12:688886. doi: 10.3389/fimmu.2021.688886. eCollection 2021. Front Immunol. 2021. PMID: 34135912 Free PMC article.
-
Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy.J Infect Dis. 2002 Oct 15;186(8):1092-7. doi: 10.1086/343802. Epub 2002 Sep 20. J Infect Dis. 2002. PMID: 12355359
-
Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction.AIDS Rev. 2015 Jul-Sep;17(3):135-46. AIDS Rev. 2015. PMID: 26450802 Review.
Cited by
-
Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients.Retrovirology. 2016 Jun 30;13(1):44. doi: 10.1186/s12977-016-0278-5. Retrovirology. 2016. PMID: 27363286 Free PMC article.
-
Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1(0 1):S79-86. doi: 10.1097/QAI.0000000000000260. J Acquir Immune Defic Syndr. 2014. PMID: 25117963 Free PMC article. Review.
-
Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications.J Clin Endocrinol Metab. 2024 Jan 18;109(2):e478-e487. doi: 10.1210/clinem/dgad411. J Clin Endocrinol Metab. 2024. PMID: 37437159 Free PMC article. Review.
-
Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction.J Infect Dis. 2022 Feb 15;225(4):661-674. doi: 10.1093/infdis/jiaa714. J Infect Dis. 2022. PMID: 33216130 Free PMC article.
-
Comparative Analysis of Immune Activation Markers of CD8+ T Cells in Lymph Nodes of Different Origins in SIV-Infected Chinese Rhesus Macaques.Front Immunol. 2016 Sep 21;7:371. doi: 10.3389/fimmu.2016.00371. eCollection 2016. Front Immunol. 2016. PMID: 27708644 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
